Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,978 | 556 | 99.8% |
| Education | $14.24 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,504 | 80 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,124 | 76 | $0 (2022) |
| Lundbeck LLC | $1,111 | 72 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $846.19 | 44 | $0 (2024) |
| ABBVIE INC. | $731.62 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $675.52 | 46 | $0 (2024) |
| Allergan, Inc. | $528.87 | 49 | $0 (2020) |
| Corium, LLC | $304.26 | 16 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $259.50 | 15 | $0 (2024) |
| Alkermes, Inc. | $250.34 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,164 | 61 | Lundbeck LLC ($227.86) |
| 2023 | $1,032 | 64 | Otsuka America Pharmaceutical, Inc. ($187.80) |
| 2022 | $1,464 | 94 | Sunovion Pharmaceuticals Inc. ($269.68) |
| 2021 | $1,334 | 95 | Takeda Pharmaceuticals U.S.A., Inc. ($235.39) |
| 2020 | $876.65 | 47 | Otsuka America Pharmaceutical, Inc. ($316.12) |
| 2019 | $1,134 | 67 | Janssen Pharmaceuticals, Inc ($353.76) |
| 2018 | $677.35 | 51 | Otsuka America Pharmaceutical, Inc. ($198.93) |
| 2017 | $1,312 | 79 | Sunovion Pharmaceuticals Inc. ($341.93) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: CNS | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/24/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: ADHD | ||||||
| 09/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: ADHD | ||||||
| 08/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: PSYCHIATRY | ||||||
| 08/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Neuropsychiatry | ||||||
| 08/06/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 109 | 234 | $26,910 | $13,289 |
| 2022 | 3 | 114 | 252 | $28,980 | $15,056 |
| 2021 | 3 | 126 | 206 | $23,690 | $12,050 |
| 2020 | 3 | 125 | 228 | $20,010 | $11,281 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 38 | 117 | $9,360 | $5,531 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 82 | $12,300 | $4,848 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 35 | $5,250 | $2,910 | 55.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 41 | 126 | $10,080 | $6,437 | 63.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 88 | $13,200 | $5,651 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 38 | $5,700 | $2,968 | 52.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 50 | 103 | $8,240 | $5,119 | 62.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 72 | $10,800 | $4,684 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 31 | $4,650 | $2,248 | 48.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 49 | 114 | $6,960 | $4,881 | 70.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 82 | $8,250 | $4,009 | 48.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 32 | $4,800 | $2,392 | 49.8% |
About Dr. David Krojanker, M.D
Dr. David Krojanker, M.D is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114900867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Krojanker, M.D has received a total of $8,993 in payments from pharmaceutical and medical device companies, with $1,164 received in 2024. These payments were reported across 558 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,978).
As a Medicare-enrolled provider, Krojanker has provided services to 474 Medicare beneficiaries, totaling 920 services with total Medicare billing of $51,677. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Saint Louis, MO
- Active Since 11/28/2005
- Last Updated 05/15/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114900867
Products in Payments
- REXULTI (Drug) $2,422
- VRAYLAR (Drug) $1,260
- LATUDA (Drug) $1,124
- TRINTELLIX (Drug) $659.43
- SPRAVATO (Drug) $627.58
- Auvelity (Drug) $238.38
- ARISTADA (Drug) $236.08
- INVEGA SUSTENNA (Drug) $210.36
- INGREZZA (Drug) $183.72
- AZSTARYS (Drug) $161.34
- Azstarys (Drug) $142.92
- HETLIOZ (Drug) $140.31
- VYVANSE (Drug) $129.20
- JORNAY PM (Drug) $108.97
- FANAPT (Drug) $103.68
- SUNOSI (Drug) $101.74
- Dayvigo (Drug) $98.27
- NUEDEXTA (Drug) $95.14
- AUSTEDO (Drug) $87.40
- CAPLYTA (Drug) $86.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Louis
Dr. Mohd Malik, M.d, M.D
Psychiatry — Payments: $1.8M
Adam Sky, Md, MD
Psychiatry — Payments: $1.4M
Dr. Junaid Syed, M.d, M.D
Psychiatry — Payments: $1.1M
Dr. Michael Stotler, Md, MD
Psychiatry — Payments: $299,451
Dr. Naji Chaaya Salloum, M.d, M.D
Psychiatry — Payments: $236,374
Dr. Devnandini Rastogi, Md, MD
Psychiatry — Payments: $230,240